Skip to main content

  • AddRemove
  • Build a Report 
Legal Update

OTC Derivatives—In the Crosshairs of US Legislative and Regulatory Change Part III: An Update

1 September 2009
Mayer Brown Legal Update
We have previously written about legislative and regulatory developments facing the over-the-counter (OTC) derivatives market. These development include a number of bills introduced in Congress as well as the framework outlined by the Department of the Treasury in the June white paper, “Financial Regulatory Reform: A New Foundation,” for a new regulatory regime for OTC derivatives to be implemented by legislation.


  • J. Paul Forrester
    T +1 312 701 7366
  • David R. Sahr
    T +44 20 3130 3496
  • Jerome J. Roche
    T +1 202 263 3773

The Build a Report feature requires the use of cookies to function properly.  Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently.  If you do not accept cookies, this function will not work.  For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.